drugset / Trial / NCT02133079
Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96
Phase 1/2
Unknown
20 enrolled
Cure&Sure Biotech Co., LTD
Chinese Academy of Medical Sciences · collab
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and effectiveness of autologous gp96 treatment of liver cancer and Pancreatic Adenocarcinoma
Timeline
- Start
- 2012-03
- Primary completion
- 2016-11
- Completion
- 2019-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | vitespen | Vaccine | — | — |